Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite

Glycobiology

Volumn 24, Issue 7, 2014, Pages 619-637

  Prasanphanich, Nina Salinger ^a   Luyai, Anthony E ^a,d   Song, Xuezheng ^a   Heimburg Molinaro, Jamie ^a   Mandalasi, Msano ^c   Mickum, Megan ^a   Smith, David F ^a   Nyame, A Kwame ^b   Cummings, Richard D ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND EASTERN SHORE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cellular engineering; glyco conjugate; helminth; LDNF; schistosome

Indexed keywords

ANTISERUM; CONCANAVALIN A; FUCOSYLATED LACDINAC ANTIGEN; GLYCAN; GLYCOCONJUGATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KIFUNENSINE; MONOCLONAL ANTIBODY; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PARASITE ANTIBODY; PARASITE ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; HELMINTH ANTIBODY; IMMUNOGLOBULIN G; LACTOSE; N-ACETYLGALACTOSAMINYL-1-4-(FUCOSYL-1,3)-N-ACETYLGLUCOSAMINE; N-ACETYLGALACTOSAMINYL-1-4-N-ACETYLGLUCOSAMINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; CELL ENGINEERING; CELL SURFACE; CHO CELL LINE; CONJUGATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION SYSTEM; GLYCOSYLATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; ANALOGS AND DERIVATIVES; ANIMAL; ANTIGEN PRESENTATION; CRICETULUS; HAMSTER; IMMUNOLOGY; SCHISTOSOMIASIS MANSONI;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGEN PRESENTATION; CELL ENGINEERING; CHO CELLS; CRICETINAE; CRICETULUS; IMMUNIZATION; IMMUNOGLOBULIN G; LACTOSE; MICE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 84901768167     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu027     Document Type: Article

References (95)

1. Ahn HJ, Kim Y-S, Lee C-H, Cho E-W, Yoo H-S, Kim S-H, Ko J-H, Kim SJ. 2011. Generation of antibodies recognizing an aberrant glycoform of human tissue inhibitor of metalloproteinase-1 (TIMP-1) using decoy immunization and phage display. J Biotechnol. 151:225-230.
2. Aranzamendi C, Tefsen B, Jansen M, Chiumiento L, Bruschi F, Kortbeek T, Smith DF, Cummings RD, Pinelli E, Van Die I. 2011. Glycan microarray profiling of parasite infection sera identifies the LDNF glycan as a potential antigen for serodiagnosis of trichinellosis. Exp Parasitol. 129:221-226.
3. Batista FD, Harwood NE. 2009. The who, how and where of antigen presentation to B cells. Nat Rev Immunol. 9:15-27.
4. Brockhaus M, Magnani JL, Blaszczyk M, Steplewski Z, Koprowski H, Karlsson K-A, Larson G, Ginsburg V. 1981. Monoclonal antibodies directed against the human Leb blood group antigen. J BiolChem. 256:13223-13225. (Pubitemid 12131987)
5. Carrasco YR, Batista FD. 2006. B cell recognition of membrane-bound antigen: An exquisite way of sensing ligands. Curr Opin Immunol. 18:286-291. (Pubitemid 44304340)
6. Caulfield JP, Cianci CML, Mcdiarmid SS, Suyemitsu T, Schmid K. 1987. Ultrastructure, carbohydrate, and amino acid analysis of two preparations of the cercarial glycocalyx of schistosoma mansoni. J Parasitol. 73:514-522.
7. Cummings RD, Etzler ME. 2009. Antibodies and lectins in glycan analysis. In: Varki A, Cummings RD, Esko JD, editors. Essentials Glycobiol. 2nd ed. New York: Cold Spring Harbor Laboratory Press.
8. Defrance T, Taillardet M, Genestier L. 2011. T cell-independent B cell memory. Curr Opin Immunol. 23:330-336.
9. De Gruijl TD, van den Eertwegh AJM, Pinedo HM, Scheper RJ. 2008. Whole-cell cancer vaccination: From autologous to allogeneic tumor-and dendritic cell-based vaccines. Cancer Immunol Immunother. 57:1569-1577.
10. Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehninger S, Koistinen R, Koistinen H, Seppala M, Clark GF. 1995. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem. 270:24116-24126.
11. De Vries T, Palcic MP, Schoenmakers PS, Van Den Eijnden DH, Joziasse DH. 1997. Acceptor specificity of GDP-Fuc:GalB1-4GlcNAc-R a3-fucosyltransferase VI (FucTVI) expressed in insect cells as soluble, secreted enzyme. Glycobiolgy. 7:921-927. (Pubitemid 27455658)
12. Diemert DJ, Pinto AG, Freire J, Jariwala A, Santiago H, Hamilton RG, Periago MV, Loukas A, Tribolet L, Mulvenna J, et al. 2012. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: Implications for the development of vaccines against helminths. J Allergy Clin Immunol. 130:169-76.e6.
13. Eberl M, Langermans JA, Vervenne RA, Nyame AK, Cummings RD, Thomas AW, Coulson PS, Wilson RA. 2001. Antibodies to glycans dominate the host response to schistosome larvae and eggs: Is their role protective or subversive? J Infect Dis. 183:1238-1247. (Pubitemid 32281563)
14. Elbein AD, Tropea JE, Mitchell M, Kaushal GP. 1990. Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. J Biol Chem. 265:15599-15605.
15. Ellis LA, Reason AJ, Morris HR, Dell A, Iglesias R, Ubeira FM, Appleton JA. 1994. Glycans as targets for monoclonal antibodies that protect rats against Trichinella spiralis. Glycobiology. 4:585-592. (Pubitemid 24327723)
16. Faveeuw C, Mallevaey T, Paschinger K, Wilson IBH, Fontaine J, Mollicone R, Oriol R, Altmann F, Lerouge P, Capron M, et al. 2003. Schistosome N-glycans containing core alpha 3-fucose and core beta 2-xylose epitopes are strong inducers of Th2 responses in mice. Eur J Immunol. 33:1271-1281. (Pubitemid 36609145)
17. Frank S, van Die I, Geyer R. 2012. Structural characterization of Schistosoma mansoni adult worm glycosphingolipids reveals pronounced differences with those of cercariae. Glycobiology. 22:676-695.
18. Good-Jacobson KL, Tarlinton DM. 2012. Multiple routes to B-cell memory. Int Immunol. 24:403-408.
19. Gryseels B, Polman K, Clerinx J, Kestens L. 2006. Human schistosomiasis. Lancet. 368:1106-1118. (Pubitemid 44402679)
20. Grzych J, Capron M, Bazin H, Capron A. 1982. In vitro and In vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. J Immunol. 129:2739-2743. (Pubitemid 13245553)
21. Grzych JM, Capron M, Dissous C, Capron A. 1984. Blocking activity of rat monoclonal antibodies in experimental schistosomiasis. J Immunol. 133:998-1004. (Pubitemid 14093501)
22. Grzych JM, Capron M, Lambert PH, Dissous C, Torres S, Capron A. 1985. An anti-idiotype vaccine against experimental schistosomiasis. Nature. 316:74-76. (Pubitemid 15013717)
23. Hansson GC, Karlsson K, Larson G, Mckibbinl JM, Herlynll M, Steplewskill Z, Koprowskill H. 1983. Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. J Biol Chem. 258:4091-4097.
24. Harn DA, Mitsuyama M, David JR. 1984. Schistosoma manosoni anti-egg monoclonal antibodies protect against cercarial challenge in vivo. J Exp Med. 159:1371-1387. (Pubitemid 14106455)
25. Heimburg-Molinaro J, Song X, Smith DF, Cummings RD. 2011. Preparation and analysis of glycan microarrays. Curr. Protoc. Protein Sci. Chapter 12, Unit 12.10, 1-33.
26. Hirohashi S, Clausen H, Yamada T, Shimosato Y, Hakomori S. 1985. Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and-81 expressed in cancer of blood group O or B individuals: Its identification as Tn antigen. Proc Natl Acad Sci USA. 82:7039-7043. (Pubitemid 16209687)
27. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A. 2010. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol. 8:814-826.
28. Hotez PJ, Engels D, Fenwick A, Savioli L. 2010. Africa is desperate for praziquantel. Lancet. 376:496-498.
29. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. 2009. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 373: 1570-1575.
30. Iwamori M, Murata M, Toyoda M, Iwamori Y. 2009. Contribution of glycolipids to species-specific antigens on erythrocytes of several animal species as to recognition of antigens with rabbit anti-glycolipids and anti-erythrocyte antisera. Glycoconj J. 26:467-476.
31. Jang-Lee J, Curwen RS, Ashton PD, Tissot B, Mathieson W, Panico M, Dell A, Wilson RA, Haslam SM. 2007. Glycomics analysis of Schistosoma mansoni egg and cercarial secretions. Mol Cell Proteomics. 6:1485-1499. (Pubitemid 47506162)
32. Kantelhardt SR, Wuhrer M, Dennis RD, Doenhoff MJ, Bickle Q, Geyer R. 2002. Fuc(alpha1->3)GalNAc-: The major antigenic motif of Schistosoma mansoni glycolipids implicated in infection sera and keyhole-limpet haemocyanin cross-reactivity. Biochem J. 366:217-223. (Pubitemid 34971821)
33. Kariuki TM, Farah IO, Wilson Ra, Coulson PS. 2008. Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes. Parasite Immunol. 30:554-562.
34. Kawar ZS, Haslam SM, Morris HR, Dell A, Cummings RD. 2005. Novel poly-GalNAcbeta1-4GlcNAc (LacdiNAc) and fucosylated poly-LacdiNAc N-glycans from mammalian cells expressing beta1,4-Nacetylgalactosaminyltransferase and alpha1,3-fucosyltransferase. J Biol Chem. 280:12810-12819.
35. Kawar ZS, Van Die I, Cummings RD. 2002. Molecular cloning and enzymatic characterization of a UDP-GalNAc:GlcNAc(beta)-R beta1,4- Nacetylgalactosaminyltransferase from Caenorhabditis elegans. J Biol Chem. 277:34924-34932.
36. Khoo KH, Sarda S, Xu X, Caulfield JP, McNeil MR, Homans SW, Morris HR, Dell A. 1995. A unique multifucosylated-3GalNAc beta 1->4GlcNAc beta 1->3Gal alpha 1-motif constitutes the repeating unit of the complex O-glycans derived from the cercarial glycocalyx of Schistosoma mansoni. J Biol Chem. 270:17114-17123.
37. Ko AI, Dräger UC, Harn DA. 1990. A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1. Proc Natl Acad Sci USA. 87:4159-4163.
38. Koprowski H, Steplewski Z, Herlyn D, Herlyn M. 1978. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA. 75:3405-3409. (Pubitemid 8395080)
39. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. 1979. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 5:957-971. (Pubitemid 10132218)
40. Lee J, Park S-H, Stanley P. 2002. Antibodies that recognize bisected complex N-glycans on cell surface glycoproteins can be made in mice lacking N-acetylglucosaminyltransferase III. Glycoconj J. 19:211-219. (Pubitemid 36851264)
41. Leppanen A, Penttila L, Renkonen O, McEver RP, Cummings RD. 2002. Glycosulfopeptides with O-glycans containing sialylated and polyfucosylated polylactosamine bind with low affinity to P-selectin. J Biol Chem. 277:39749-39759. (Pubitemid 35190958)
42. Lewis F. 1998. Schistosomiasis. Curr. Protoc. Immunol. 19.1.1-19.1.28.
43. Lin FYC, Ho VA, Khiem HB, Trach DD, Bay PV, Thang TC, Kossaczka Z, Bryla DA, Shiloach J, Robbins JB, et al. 2001. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med. 344:1263-1269. (Pubitemid 32372960)
44. Luyai AE, Heimburg-Molinaro J, Prasanphanich NS, Mickum ML, Lasanajak Y, Song X, Nyame AK, Wilkins P, Rivera-Marrero CA, Smith DF, et al. 2014. Differential expression of anti-glycan antibodies in schistosomeinfected humans, rhesus monkeys and mice. Glycobiology. 24:602-618.
45. Mandalasi M. 2011. Immunity to schistosomiasis: Studies on the correlation between schistosome glycan antigen expression and host humoral responses. Chapter 4: Characterization of the binding specificities of IgG monoclonal antibodies to lacdiNAc (GalNAcβ1-4GlcNAc-R) and fucosylated lacdiNAc (GalNAcβ1-4[Fucα1-3]GlcNAc-R) glycan epitopes derived from splenocytes of Schistosoma mansoni infected mice. Doctoral dissertation. University of Maryland Eastern Shore, Princess Anne, MD, p. 74.
46. Mandalasi M, Dorabawila N, Smith DF, Heimburg-molinaro J, Nyame AK, Cummings RD. 2013. Development and characterization of a specific IgG monoclonal antibody toward the Lewis x antigen using splenocytes of Schistosoma mansoni infected mice. Glycobiology. 23:877-892.
47. Mcmanus DP, Loukas A. 2008. Current status of vaccines for schistosomiasis. Clin Microbiol Rev. 21:225-242. (Pubitemid 351160017)
48. Milani a, Sangiolo D, Montemurro F, Aglietta M, Valabrega G. 2013. Active immunotherapy in HER2 overexpressing breast cancer: Current status and future perspectives. Ann Oncol. 24:1740-1748.
49. Naus CWA, Booth M, Jones FM, Kemijumbi J, Vennervald BJ, Kariuki CH, Ouma JH, Kabatereine NB, Dunne DW. 2003. The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community. Trop Med Int Heal. 8:561-568. (Pubitemid 36724021)
50. Naus CWA, Remoortere AVan, Ouma JH, Kimani G, Dunne DW, Kamerling JP, Deelder M, Hokke CH. 2003. Specific antibody responses to three schistosome-related carbohydrate structures in recently exposed immigrants and established residents in an area of Schistosoma mansoni endemicity. Infect Immun. 71:5676-5681. (Pubitemid 37205620)
51. Nyame AK, Kawar ZS, Cummings RD. 2004. Antigenic glycans in parasitic infections: Implications for vaccines and diagnostics. Arch Biochem Biophys. 426:182-200. (Pubitemid 38680616)
52. Nyame AK, Leppänen AM, Bogitsh BJ, Cummings RD. 2000. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes. Exp Parasitol. 96:202-212. (Pubitemid 32195398)
53. Nyame AK, Lewis FA, Doughty BL, Correa-Oliveira R, Cummings RD. 2003. Immunity to schistosomiasis: Glycans are potential antigenic targets for immune intervention. Exp Parasitol. 104:1-13. (Pubitemid 41123180)
54. Nyame AK, Yoshino TP, Cummings RD. 2002. Differential expression of LacdiNAc, Fucosylated LacdiNAc, and Lewis x glycan antigens in intramolluscan stages of Schistosoma manosni. J Parasitol. 88:890-897. (Pubitemid 35278733)
55. Oelmann S, Stanley P, Gerardy-Schahn R. 2001. Point mutations identified in Lec8 Chinese hamster ovary glycosylation mutants that inactivate both the UDP-galactose and CMP-sialic acid transporters. J Biol Chem. 276: 26291-26300.
56. Okano M, Satoskar AR, Nishizaki K, Abe M, Harn DA, Jr. 1999. Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol. 163:6712-6717.
57. Okano M, Satoskar AR, Nishizaki K, Harn DA, Jr. 2001. Lacto-Nfucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol. 167:442-450. (Pubitemid 32567810)
58. Omer-Ali P, Magee AI, Kelly C, Simpson AJG. 1986. A major role for carbohydrate epitopes preferentially recognized by chronically infected mice in the determination of Schistosoma mansoni schistosomulum surface antigenicity. J Immunol. 137:3601-3607. (Pubitemid 17193323)
59. Omer Ali P, Mansour M, Woody JN, Smithers SR, Simpson AJ. 1989. Antibody to carbohydrate and polypeptide epitopes on the surface of schistosomula of Schistosoma mansoni in Egyptian patients with acute and chronic schistosomiasis. Parasitology. 98 Pt 3:417-424. (Pubitemid 19175409)
60. Omer Ali P, Smithers SR, Bickle Q, Phillips SM, Harn D, Simpson AJG. 1988. Analysis of the anti-Schistosoma mansoni surface antibody response during murine infection and its potential contribution to protective immunity. J Immunol. 140:3273-3279.
61. Palucka K, Banchereau J. 2013. Dendritic-cell-based therapeutic cancer vaccines. Immunity. 39:38-48.
62. Patnaik SK, Stanley P. 2006. Lectin-resistant CHO glycosylation mutants. Methods Enzymol. 416:159-182. (Pubitemid 44750110)
63. PengW, Pranskevich J, Nycholat C, Gilbert M, Wakarchuk W, Paulson JC, Razi N. 2012. Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans. Glycobiology. 22:1453-1464.
64. Prasanphanich NS, Mickum ML, Heimburg-Molinaro J, Cummings RD. 2013. Glycoconjugates in host-Helminth interactions. Front Immunol. 4:240.
65. Robijn MLM, Koeleman CaM, Wuhrer M, Royle L, Geyer R, Dwek Ra, Rudd PM, Deelder AM, Hokke CH. 2007. Targeted identification of a unique glycan epitope of Schistosoma mansoni egg antigens using a diagnostic antibody. Mol Biochem Parasitol. 151:148-161. (Pubitemid 46054210)
66. Robijn MLM, Wuhrer M, Kornelis D, Deelder aM, Geyer R, Hokke CH. 2005. Mapping fucosylated epitopes on glycoproteins and glycolipids of Schistosoma mansoni cercariae, adult worms and eggs. Parasitology. 130:67-77.
67. Samuelson JC, Caulfield JP. 1985. The cercarial glycocalyx of Schistosoma mansoni. J Cell Biol. 100:1423-1434. (Pubitemid 15098017)
68. Seko A, Koketsu M, Nishizono M, Enoki Y, Ibrahim HR, Juneja LR, Kim M, Yamamoto T. 1997. Occurrence of a sialylglycopeptide and free sialylglycans in hen's egg yolk. Biochim Biophys Acta. 1335:23-32. (Pubitemid 27174503)
69. Song X, Heimburg-Molinaro J, Dahms NM, Smith DF, Cummings RD. 2012. Carbohydrate microarrays: Preparation of a mannose-6-phosphate glycan miroarray through fluorescent derivatization, phosphorylation, and immobilization of natural high-mannose N-glycans and application in ligand identification of P-type lectins. Methods Mol Biol. 808:137-148.
70. Song X, Xia B, Stowell SR, Lasanajak Y, Smith DF, Cummings RD. 2009. Novel fluorescent glycan microarray strategy reveals ligands for galectins. Chem Biol. 16:36-47.
71. Srivatsan S, Patel J, Bozeman E, Imasuen I, He S, Daniels D, Selvaraj P. 2014. Allogeneic tumor cell vaccines: The promise and limitations in clinical trials. Hum Vaccin Immunother. 10:52-63.
72. Srivatsan J, Smith DF, Cummings RD. 1992a. Schistosoma mansoni synthesizes novel biantennary Asn-linked oligosaccharides containing terminal B-linked N-acetylgalactosamine. Glycobiology. 2:445-452.
73. Srivatsan J, Smith DF, Cummings RD. 1992b. The human blood fluke Schistosoma mansoni synthesizes glycoproteins containing the Lewis X antigen. J Biol Chem. 267:20196-20203.
74. Stanley P. 1980. Altered Glycolipids of CHO Cells Resistant to Wheat-Germ Agglutinin. Sweeley CC, editor. American Chemical Society Symposium Series No. 128. American Chemical Society. p. 213-221.
75. The World Health Organization 2008. The Global Burden of Disease: 2004 Update. http://www.who.int/topics/global-burden-of-disease/en/.
76. The World Health Organization 2010. Working to Overcome the Global Impact of Neglected Tropical Diseases: First WHO Report on Neglected Tropical Diseases. http://www.who.int/neglected-diseases/2010report/en/.
77. Thomas PG, Harn DA, Jr. 2004. Immune biasing by helminth glycans. Cell Microbiol. 6:13-22. (Pubitemid 38111585)
78. Van de Vijver KK, Deelder AM, Jacobs W, van Marck EA, Hokke CH. 2006. LacdiNAc-and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation. Glycobiology. 16:237-243. (Pubitemid 43264690)
79. Van de Vijver KK, Hokke CH, van Remoortere A, Jacobs W, Deelder AM, Van Marck Ea. 2004. Glycans of Schistosoma mansoni and keyhole limpet haemocyanin induce hepatic granulomas in vivo. Int J Parasitol. 34:951-961. (Pubitemid 38813257)
80. Van den Eijnden DH, Neeleman AP, Van der Knap WPW, Bakker H, Agterberg M, van Die I. 1995. Novel glycosylation routes for glycoproteins: The lacdiNAc pathway. Biochem Soc Trans. 23:175-179.
81. Van Den Nieuwenhof IM, Koistinen H, Easton RL, Koistinen R, Kamarainen M, Morris HR, Die I Van, Seppala M, Dell A, Van Den Eijnden DH. 2000. Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in Chinese hamster ovary cells. Eur J Biochem. 267: 4753-4762. (Pubitemid 30619466)
82. Van Die I, van Vliet SJ, Nyame AK, Cummings RD, Bank CMC, Appelmelk B, Geijtenbeek TBH, van Kooyk Y. 2003. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology. 13:471-478. (Pubitemid 36665421)
83. Van Diepen A, Smit CH, van Egmond L, Kabatereine NB, Pinot de Moira A, Dunne DW, Hokke CH. 2012. Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray. PLoS Negl Trop Dis. 6:e1922.
84. Van Diepen A, Van der Velden NSJ, Smit CH, Meevissen MHJ, Hokke CH. 2012. Parasite glycans and antibody-mediated immune responses in Schistosoma infection. Parasitology. 139:1219-1230.
85. Van Liempt E, Bank CMC, Mehta P, Garciá-Vallejo JJ, Kawar ZS, Geyer R, Alvarez Ra, Cummings RD, Kooyk Y Van, van Die I. 2006. Specificity of DC-SIGN for mannose-and fucose-containing glycans. FEBS Lett. 580:6123-6131. (Pubitemid 44666793)
86. Van Remoortere A, van Dam GJ, Hokke CH, can den Eijnden DH, van Die I, Deelder AM. 2001. Profiles of immunoglobulin M (IgM) and IgG antibodies against defined carbohydrate epitopes in sera of Schistosoma-infected individuals determined by surface plasmon resonance. Infect Immun. 69:2396-2401. (Pubitemid 32239709)
87. Van Remoortere A, Hokke CH, van Dam GJ, van Die I, Deelder AM, van den Eijnden DH. 2000. Various stages of Schistosoma express Lewis x, LacdiNAc, GalNAcβ1-4 (Fucα1-3)GlcNAc and GalNAcβ1-4(Fucα1- 2Fucα1-3)GlcNAc carbohydrate epitopes: Detection with monoclonal antibodies that are characterized by enzymatically synthesized neoglycoproteins. Glycobiology. 10:601-609. (Pubitemid 30398415)
88. Van Stijn CMW, van den Broek M, Vervelde L, Alvarez Ra, Cummings RD, Tefsen B, van Die I. 2010. Vaccination-induced IgG response to Galalpha1-3GalNAc glycan epitopes in lambs protected against Haemonchus contortus challenge infection. Int J Parasitol. 40:215-222.
89. Van Stijn CMW, Meyer S, van den Broek M, Bruijns SCM, van Kooyk Y, Geyer R, van Die I. 2010. Schistosoma mansoni worm glycolipids induce an inflammatory phenotype in human dendritic cells by cooperation of TLR4 and DC-SIGN. Mol Immunol. 47:1544-1552.
90. Vervelde L, Bakker N, Kooyman FNJ, Cornelissen AWCa, Bank CMC, Nyame AK, Cummings RD, van Die I. 2003. Vaccination-induced protection of lambs against the parasitic nematode Haemonchus contortus correlates with high IgG antibody responses to the LDNF glycan antigen. Glycobiology. 13:795-804. (Pubitemid 37407109)
91. Weckx LY, Thompson A, Berezin EN, de Faria SM, da Cunha CA, Pride M, Patterson S, Gruber WC, Emini Ea, Scott Da. 2012. A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil. Vaccine. 30:7566-7572.
92. Wilson RA, Langermans JAM, Van Dam GJ, Vervenne RA, Hall SL, Borges WC, Dillon GP, Thomas AW, Coulson PS. 2008. Elimination of Schistosoma mansoni adult worms by rhesus macaques: Basis for a therapeutic vaccine? PLoS Negl Trop Dis. 2:8.
93. Wuhrer M, Koeleman CAM, Deelder AM, Hokke CH. 2006. Repeats of LacdiNAc and fucosylated LacdiNAc on N-glycans of the human parasite Schistosoma mansoni. FEBS J. 273:347-361.
94. Wuhrer M, Koeleman CAM, Fitzpatrick JM, Hoffmann KF, Deelder AM, Hokke CH. 2006. Gender-specific expression of complex-type N-glycans in schistosomes. Glycobioogy. 16:991-1006. (Pubitemid 44390940)
95. Yates AD, Watkins WM. 1983. Enzymes involved in the biosynthesis of glycoconjugates: A UDP-2-acetamido-2-deoxy-D-glucose: B-D-galactopyranosyl-(1-4) -saccharide (1-3)-2-acetamido-2-deoxy-B-D-glucopyranosyltransferase in human serum. Carbohydr Res. 120:251-268.